Definium Therapeutics
8 followers
Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one,... Read more
Org chart
Mark Sullivan
Chief Legal Officer
Vacant position
Brandi Roberts
Chief Financial Officer
Beth Calitri
Vice President Corporate Communications
Tomas S.
Senior Staff Infrastructure Engineer
Miguel Amável Pinheiro
Machine Learning Lead
Alex Cucerov
Senior Director, Commercial Operations And Business Intelligence
Suzuko Kitazawa
Director Of Finance
Gitanjali Jain
Vice President, Head Of Investor Relations
Robert Flath
Vice President, Finance & Strategy
Dan Gavin
Head Of Talent Acquisition
Martin Majernik
Director Of Product Life Cycle
Nicholas Hall
Scientist Pharmaceutical Development
Jenna Scoggins
Clinical Operations Manager, Digital Medicine
Javier Muniz
VP, Research & Development Strategy
Jesika C.
Associate Director CMC Quality Assurance
Derek Louie
Associate Director
Katie Kelly
Associate Director, TMF Operations Manager
Christine Oman
Clinical Trial Manager
Board & advisors
Leonard Latchman
Co-Founder
Andreas Krebs
Vice Chair
Roger Crystal
Director
Suzanne Bruhn
Board Member
Robert C. Malenka
Chair of Advisory Board
John Rotrosen
Advisor
Kenneth Alper
Advisor
Matthew W. Johnson
Advisor
Natalie Wheeler
Advisor
Sarah McCallum
Advisor
Stanley D. Glick
Advisor
Peter Gasser
Advisor
Matthias Liechti
Advisor
Kim Kuypers
Advisor
Sarah Y. Vinson
Director
Maurizio Fava
Advisor
Peter Bergethon
Advisor
Maria A. Oquendo
Advisor
Bryan L. Roth
Advisor
Robert Dworkin
Advisor
Paul Summergrad
Advisor
Nzinga Harrison
Advisor